Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Mibc × Gemcitabine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 17 Non-Muscle Invasive Bladder Neoplasms 6 Nasopharyngeal Carcinoma 6 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Nasopharyngeal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Cholangiocarcinoma 3 Recurrence 2 Pancreatic Cancer Resectable 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Klatskin Tumor 2 Bile Duct Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Rhabdoid Tumor 1 Rare Tumour 1 Pathologic Complete Response 1 Pancreatic cancer, adult 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Mibc 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphatic Metastasis 1 Lung Diseases, Interstitial 1 Locally Advanced Pancreatic Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06623162 2024-10-04

SASAN-SPARING

Fundación de investigación HM

Phase 2 Not yet recruiting

Mibc

Data powered by HemOnc (CC BY 4.0) Colophon ⚡